NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Clene Inc (NASDAQ: CLNN)

 
CLNN Technical Analysis
5
As on 9th Jun 2023 CLNN STOCK Price closed @ 1.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.79 & Strong Sell for SHORT-TERM with Stoploss of 3.21 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CLNNSTOCK Price

Open 1.04 Change Price %
High 1.05 1 Day -0.03 -2.83
Low 1.01 1 Week 0.06 6.19
Close 1.03 1 Month 0.06 6.19
Volume 80760 1 Year -3.25 -75.93
52 Week High 4.83 | 52 Week Low 0.88
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
CLNN
Daily Charts
CLNN
Intraday Charts
Whats New @
Bazaartrend
CLNN
Free Analysis
 
CLNN Important Levels Intraday
RESISTANCE1.11
RESISTANCE1.08
RESISTANCE1.07
RESISTANCE1.05
SUPPORT1.01
SUPPORT0.99
SUPPORT0.98
SUPPORT0.95
 
CLNN Forecast April 2024
4th UP Forecast4.34
3rd UP Forecast3.28
2nd UP Forecast2.62
1st UP Forecast1.97
1st DOWN Forecast0.09
2nd DOWN Forecast-0.56
3rd DOWN Forecast-1.22
4th DOWN Forecast-2.28
 
CLNN Weekly Forecast
4th UP Forecast2.63
3rd UP Forecast2.12
2nd UP Forecast1.80
1st UP Forecast1.48
1st DOWN Forecast0.58
2nd DOWN Forecast0.26
3rd DOWN Forecast-0.06
4th DOWN Forecast-0.57
 
CLNN Forecast2024
4th UP Forecast9.28
3rd UP Forecast6.63
2nd UP Forecast5
1st UP Forecast3.36
1st DOWN Forecast-1.3
2nd DOWN Forecast-2.94
3rd DOWN Forecast-4.57
4th DOWN Forecast-7.22
 
 
CLNN Other Details
Segment EQ
Market Capital 337584928.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CLNN Address
CLNN
 
CLNN Latest News
 
Your Comments and Response on Clene Inc
 
CLNN Business Profile
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company's products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah. Address: 6550 South Millrock Drive, Salt Lake City, UT, United States, 84121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service